The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging
Open accessAbstract
Glycation is both a physiological and pathological process which mainly affects proteins, nucleic acids and lipids. Exogenous and endogenous glycation produces deleterious reactions that take place principally in the extracellular matrix environment or within the cell cytosol and organelles. Advanced glycation end product (AGE) formation begins by the non-enzymatic glycation of free amino groups by sugars and aldehydes which leads to a succession of rearrangements of intermediate compounds and ultimately to irreversibly bound products known as AGEs. Epigenetic factors, oxidative stress, UV and nutrition are important causes of the accumulation of chemically and structurally different AGEs with various biological reactivities. Cross-linked proteins, deriving from the glycation process, present both an altered structure and function. Nucleotides and lipids are particularly vulnerable targets which can in turn favor DNA mutation or a decrease in cell membrane integrity and associated biological pathways respectively. In mitochondria, the consequences of glycation can alter bioenergy production. Under physiological conditions, anti-glycation defenses are sufficient, with proteasomes preventing accumulation of glycated proteins, while lipid turnover clears glycated products and nucleotide excision repair removes glycated nucleotides. If this does not occur, glycation damage accumulates, and pathologies may develop. Glycation-induced biological products are known to be mainly associated with aging, neurodegenerative disorders, diabetes and its complications, atherosclerosis, renal failure, immunological changes, retinopathy, skin photoaging, osteoporosis, and progression of some tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Advanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · cited 1×
“The Honolulu-Asia Aging Study demonstrated that diabetic subjects had a significantly higher risk of developing Alzheimer's disease, vascular dementia, and memory loss [161-163].”
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
BROWNLEE, M., VLASSARA, H., & CERAMI, A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-527 · Cited by 1,007
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Epigenetic mechanisms of longevity and aging
Sen, P., Shah, P. P., Nativio, R., & Berger, S. L. (2016) · Cell · doi:10.1016/j.cell.2016.07.050 · Cited by 956
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Stary, H. C. (1989) · PubMed · Cited by 726
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
King, P., Peacock, I., & Donnelly, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00092.x · Cited by 695
Reaction of Monosaccharides with Proteins: Possible Evolutionary Significance
Bunn, H. F., & Higgins, P. J. (1981) · Science · doi:10.1126/science.12192669 · Cited by 598
Advanced glycation end products: Key players in skin aging?
Gkogkolou, P., & Böhm, M. (2012) · Dermato-Endocrinology · doi:10.4161/derm.22028 · Cited by 584
Uribarri, J., Cai, W., Peppa, M., Goodman, S., Ferrucci, L., Striker, G., & Vlassara, H. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.427 · Cited by 570
Raucci, A., Cugusi, S., Antonelli, A., Barabino, S. M., Monti, L., Bierhaus, A., Reiss, K., Saftig, P., & Bianchi, M. E. (2008) · The FASEB Journal · doi:10.1096/fj.08-109033 · Cited by 555
Does accumulation of advanced glycation end products contribute to the aging phenotype?
Semba, R. D., Nicklett, E. J., & Ferrucci, L. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq074 · Cited by 490
TANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192203399 · Cited by 447
Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative Diseases
Sasaki, N., Fukatsu, R., Tsuzuki, K., Hayashi, Y., Yoshida, T., Fujii, N., Koike, T., Wakayama, I., Yanagihara, R., Garruto, R., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65659-3 · Cited by 408
Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study
Xu, W. L., Qiu, C. X., Wahlin, A., Winblad, B., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 407
The role of glutathione in detoxication
Ketterer, B., Coles, B., & Meyer, D. J. (1983) · Environmental Health Perspectives · doi:10.1289/ehp.834959 · Cited by 396
Esposito, C., Gerlach, H., Brett, J., Stern, D., & Vlassara, H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1387 · Cited by 380
Tan, G. S., Cheung, N., Simó, R., Cheung, G. C. M., & Wong, T. Y. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30052-3 · Cited by 361
Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease
Rabbani, N., & Thornalley, P. J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.140 · Cited by 353
Role of Advanced Glycation End Products in Diabetic Nephropathy
Forbes, J. M., Cooper, M. E., Oldfield, M. D., & Thomas, M. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077413.41276.17 · Cited by 351
Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335 · cited 2×
“Its movement from the brain to blood is mediated by the LDL receptor-related protein-1 [178, 184].”
BackgroundThe role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
Alavi Naini, S. M., & Soussi-Yanicostas, N. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/151979 · Cited by 316
Role of Advanced Glycation End Products in Diabetic Neuropathy
Sugimoto, K., Yasujima, M., & Yagihashi, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139774 · Cited by 315
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Forbes, J. M., Yee, L. T. L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1813 · Cited by 314
MacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313
The AGE‐receptor in the pathogenesis of diabetic complications
Vlassara, H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.233 · Cited by 301
Caldwell, R. B., Bartoli, M., Behzadian, M. A., El‐Remessy, A. E. B., Al‐Shabrawey, M., Platt, D. H., & Caldwell, R. W. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.415 · Cited by 293
Role of RAGE in Alzheimer’s Disease
Cai, Z., Liu, N., Wang, C., Qin, B., Zhou, Y., Xiao, M., Chang, L., Yan, L.-J., & Zhao, B. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0233-3 · Cited by 285
Quehenberger, P., Bierhaus, A., Fasching, P., Muellner, C., Klevesath, M., Hong, M., Stier, G., Sattler, M., Schleicher, E., Speiser, W., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1561 · Cited by 283
Ajandouz, E. H., & Puigserver, A. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980928z · Cited by 280
Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase
YAN, H., & HARDING, J. J. (1997) · Biochemical Journal · doi:10.1042/bj3280599 · Cited by 259
Beisswenger, P. J., Makita, Z., Curphey, T. J., Moore, L. L., Jean, S., Brinck-Johnsen, T., Bucala, R., & Vlassara, H. (1995) · Diabetes · doi:10.2337/diab.44.7.824 · Cited by 253
Geroldi, D., Falcone, C., & Emanuele, E. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585013 · Cited by 249
Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M., & Horiuchi, S. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0408h.x · Cited by 248
Birlouez-Aragon, I., Saavedra, G., Tessier, F. J., Galinier, A., Ait-Ameur, L., Lacoste, F., Niamba, C.-N., Alt, N., Somoza, V., & Lecerf, J.-M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28737 · Cited by 246
Uremic Toxicity of Advanced Glycation End Products in CKD
Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., & Boullier, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101047 · Cited by 242
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Chuah, Y. K., Basir, R., Talib, H., Tie, T. H., & Nordin, N. (2013) · International Journal of Inflammation · doi:10.1155/2013/403460 · Cited by 240
Lu, C., He, J. C., Cai, W., Liu, H., Zhu, L., & Vlassara, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401588101 · Cited by 228
Emanuele, E., D’Angelo, A., Tomaino, C., Binetti, G., Ghidoni, R., Politi, P., Bernardi, L., Maletta, R., Bruni, A. C., & Geroldi, D. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1734 · Cited by 218
Advanced Glycation End Product Recognition by the Receptor for AGEs
Xue, J., Rai, V., Singer, D., Chabierski, S., Xie, J., Reverdatto, S., Burz, D. S., Schmidt, A. M., Hoffmann, R., & Shekhtman, A. (2011) · Structure · doi:10.1016/j.str.2011.02.013 · Cited by 217
DeGroot, J., Verzijl, N., Wenting‐Van Wijk, M. J. G., Jacobs, K. M. G., Van El, B., Van Roermund, P. M., Bank, R. A., Bijlsma, J. W. J., TeKoppele, J. M., & Lafeber, F. P. J. G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20170 · Cited by 215
Hogan, M., Cerami, A., & Bucala, R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115928 · Cited by 209
Protein carbamylation is a hallmark of aging
Gorisse, L., Pietrement, C., Vuiblet, V., Schmelzer, C. E. H., Köhler, M., Duca, L., Debelle, L., Fornès, P., Jaisson, S., & Gillery, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517096113 · Cited by 208
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
Hammes, H.-P., Alt, A., Niwa, T., Clausen, J. T., Bretzel, R. G., Brownlee, M., & Schleicher, E. D. (1999) · Diabetologia · doi:10.1007/s001250051221 · Cited by 205
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
Biao, X., Chibber, R., Ruggiero, D., Kohner, E., Ritter, J., & Ferro, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0490fje · Cited by 195
Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., & Yamamoto, H. (1998) · Diabetologia · doi:10.1007/s001250051089 · Cited by 194
Regulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106534200 · Cited by 191
Duran-Jimenez, B., Dobler, D., Moffatt, S., Rabbani, N., Streuli, C. H., Thornalley, P. J., Tomlinson, D. R., & Gardiner, N. J. (2009) · Diabetes · doi:10.2337/db09-0320 · Cited by 186
Rabbani, N., & Thornalley, P. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361045 · Cited by 184
Advanced Glycation End-Products Induce Tubular CTGF via TGF-β–Independent Smad3 Signaling
Chung, A. C. K., Zhang, H., Kong, Y.-Z., Tan, J.-J., Huang, X. R., Kopp, J. B., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010018 · Cited by 180
RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1030 · Cited by 177
Mizutari, K., Ono, T., Ikeda, K., Kayashima, K., & Horiuchi, S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12292244 · Cited by 175
The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Moore, T. C. B., Moore, J. E., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Campbell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B., et al. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1063 · Cited by 172
Heitner, J., & Dickson, D. (1997) · Neurology · doi:10.1212/wnl.49.5.1306 · Cited by 171
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
Mott, J. D., Khalifah, R. G., Nagase, H., Shield, C. F., Hudson, J. K., & Hudson, B. G. (1997) · Kidney International · doi:10.1038/ki.1997.455 · Cited by 170
Salahuddin, P., Rabbani, G., & Khan, R. (2014) · Cellular and Molecular Biology Letters · doi:10.2478/s11658-014-0205-5 · Cited by 167
Berrou, J., Fougeray, S., Venot, M., Chardiny, V., Gautier, J., Dulphy, N., Toubert, A., & Péraldi, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062418 · Cited by 166
Biology of Healthy Aging and Longevity
Carmona, J. J., & Michan, S. (2016) · Revista de Investigación Clínica · doi:10.1016/s0034-8376(25)00202-5 · Cited by 166
Laminin Alterations After In Vitro Nonenzymatic Glycosylation
Charonis, A. S., Reger, L. A., Dege, J. E., Kouzi-Koliakos, K., Furcht, L. T., Wohlhueter, R. M., & Tsilibary, E. C. (1990) · Diabetes · doi:10.2337/diab.39.7.807 · Cited by 164
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation
Guglielmotto, M., Aragno, M., Tamagno, E., Vercellinatto, I., Visentin, S., Medana, C., Catalano, M. G., Smith, M. A., Perry, G., Danni, O., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.026 · Cited by 163
Alikhani, M., MacLellan, C. M., Raptis, M., Vora, S., Trackman, P. C., & Graves, D. T. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2006 · Cited by 162
Sugimoto, K., Nishizawa, Y., Horiuchi, S., & Yagihashi, S. (1997) · Diabetologia · doi:10.1007/s001250050839 · Cited by 159
Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy
Sabanayagam, C., Yip, W., Ting, D. S. W., Tan, G., & Wong, T. Y. (2016) · Ophthalmic Epidemiology · doi:10.1080/09286586.2016.1193618 · Cited by 159
Fuller, S. L., Steele, M. L., & Münch, G. W. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.08.016 · Cited by 158
The pathogenic role of Maillard reaction in the aging eye
Nagaraj, R. H., Linetsky, M. D., & Stitt, A. W. (2010) · Amino Acids · doi:10.1007/s00726-010-0778-x · Cited by 154
Postural Control and Gait Performance in the Diabetic Peripheral Neuropathy: A Systematic Review
Mustapa, A., Justine, M., Mustafah, N. M., Jamil, N., & Manaf, H. (2016) · BioMed Research International · doi:10.1155/2016/9305025 · Cited by 151
van Heijst, J. W. J., Niessen, H. W. M., Hoekman, K., & Schalkwijk, C. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.084 · Cited by 145
Miele, C., Riboulet, A., Maitan, M. A., Oriente, F., Romano, C., Formisano, P., Giudicelli, J., Bèguinot, F., & OBBERGHEN, E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301088200 · Cited by 141
DNA damage by carbonyl stress in human skin cells
Roberts, M. J., Wondrak, G. T., Cervantes-Laurean, D., Jacobson, M. K., & Jacobson, E. L. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00232-4 · Cited by 139
Yoshida, N., Okumura, K.-I., & Aso, Y. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.014 · Cited by 138
Glycation (non-enzymic glycosylation) inactivates glutathione reductase
Blakytny, R., & Harding, J. J. (1992) · Biochemical Journal · doi:10.1042/bj2880303 · Cited by 137
Vimentin Is the Specific Target in Skin Glycation
Kueper, T., Grune, T., Prahl, S., Lenz, H., Welge, V., Biernoth, T., Vogt, Y., Muhr, G., Gaemlich, A., Jung, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701586200 · Cited by 136
Lohwasser, C., Neureiter, D., Weigle, B., Kirchner, T., & Schuppan, D. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700070 · Cited by 135
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.
Arbor, S., LaFontaine, M., & Cumbay, M. G. (2016) · PubMed Central · Cited by 135
Evaluation of rage isoforms, ligands, and signaling in the brain
Ding, Q., & Keller, J. N. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.08.006 · Cited by 130
Effect of advanced glycation end product intake on inflammation and aging: a systematic review
Puyvelde, K. V., Mets, T. F., Njemini, R., Beyer, I., & Bautmans, I. (2014) · Nutrition Reviews · doi:10.1111/nure.12141 · Cited by 129
Glycation as the glucose link to diabetic complications.
Gugliucci, A. (2000) · PubMed · Cited by 128
Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease
Takeuchi, M., Kikuchi, S., Sasaki, N., Suzuki, T., 渡井孝幸, Iwaki, M., Bucala, R., & Yamagishi, S. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480582 · Cited by 127
Involvement of RAGE, MAPK and NF‐κB pathways in AGEs‐induced MMP‐9 activation in HaCaT keratinocytes
Zhu, P., Ren, M., Yang, C. H., Hu, Y., Ran, J., & Yan, L. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01408.x · Cited by 126
Curtis, T. M., Hamilton, R. W., Yong, P. H., McVicar, C. M., Berner, A., Pringle, R., Uchida, K., Nagai, R., Brockbank, S., & Stitt, A. W. (2010) · Diabetologia · doi:10.1007/s00125-010-1971-x · Cited by 123
Mastorikou, M., Mackness, B., Liu, Y., & Mackness, M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02546.x · Cited by 122
Ahmad, S., Moinuddin, Dixit, K., Shahab, U., Alam, K., & Ali, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.064 · Cited by 121
Role of Growth Factors in the Development of Diabetic Complications
Chiarelli, F., Santilli, F., & Mohn, A. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023515 · Cited by 120
The effect of advanced glycation end-product formation upon cell-matrix interactions
Paul, R. G., & Bailey, A. J. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00023-0 · Cited by 118
Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage
Nigro, C., Leone, A., Raciti, G. A., Longo, M., Mirra, P., Formisano, P., Bèguinot, F., & Miele, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010188 · Cited by 116
RAGE Ligand Upregulation of VEGF Secretion in ARPE-19 Cells
Ma, W., Lee, S. E., Guo, J., Qu, W., Hudson, B. I., Schmidt, A. M., & Barile, G. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0738 · Cited by 114
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
Sanguineti, R., Puddu, A., Mach, F., Montecucco, F., & Viviani, G. L. (2014) · Mediators of Inflammation · doi:10.1155/2014/975872 · Cited by 112
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
Handa, J. T., Cano, M., Wang, L., Datta, S., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.013 · Cited by 112
Turk, Z., Ljubic, S., Turk, N., & Benko, B. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00389-2 · Cited by 111
Advanced Glycation End Products in Nondiabetic Patients With Coronary Artery Disease
Kanauchi, M., Tsujimoto, N., & Hashimoto, T. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1620 · Cited by 111
Nutrition and aging skin: Sugar and glycation
Danby, F. W. (2010) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2010.03.018 · Cited by 107
Guo, Q., Mori, T., Jiang, Y., Hu, C., Osaki, Y., Yoneki, Y., Sun, Y., Hosoya, T., Kawamata, A., Ogawa, S., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832c419a · Cited by 105
Sekido, H., Suzuki, T., Jomori, T., Takeuchi, M., Yabe‐Nishimura, C., & Yagihashi, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.159 · Cited by 105
Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress
Lin, N., Zhang, H., & Su, Q. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.01.003 · Cited by 103 · cited 1×
“Glycation also lowers insulin secretion while AGEs also have a direct effect on the pancreas and create the conditions for oxidation, leading to the malfunction and death of insulin secreting beta cells [28, 31, 32].”
BackgroundMasaki, H., Okano, Y., & Sakurai, H. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00056-2 · Cited by 100
Takeuchi, M., Takino, J.-I., Furuno, S., Shirai, H., Kawakami, M., Muramatsu, M., Kobayashi, Y., & Yamagishi, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118652 · Cited by 99
Pageon, H. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.09.009 · Cited by 99
Nutrition, Epigenetics, and Diseases
Jang, H., & Serra, C. (2014) · Clinical Nutrition Research · doi:10.7762/cnr.2014.3.1.1 · Cited by 99
Toosizadeh, N., Mohler, J. M., Armstrong, D. G., Talal, T. K., & Najafi, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135255 · Cited by 98
Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs
Lee, E. J., Kim, J. Y., & Oh, S. H. (2016) · Scientific Reports · doi:10.1038/srep27848 · Cited by 98
Recent development of plant products with anti-glycation activity: a review
Chinchansure, A. A., Korwar, A. M., Kulkarni, M. J., & Joshi, S. P. (2015) · RSC Advances · doi:10.1039/c4ra14211j · Cited by 96
Regulation of autophagy by mitochondrial phospholipids in health and diseases
Hsu, P., & Shi, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.08.003 · Cited by 96
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease
Perry, G. L., Lee, H., Lee, H. P., Zhu, X., Smith, M. A., Rolston, R. K., Marlatt, M. W., Castellani, R. J., Nunomura, A., Casadesús, G., et al. (2010) · International Journal of Biomedical Science · doi:10.59566/ijbs.2010.6225 · Cited by 94
Diabète sucré, stress oxydant et produits de glycation avancée
Bonnefont‐Rousselot, D., Beaudeux, J., Thérond, P., Peynet, J., Legrand, A., & Delattre, J. (2004) · Annales Pharmaceutiques Françaises · doi:10.1016/s0003-4509(04)94297-6 · Cited by 92
Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.
Witztum, J. L., Steinbrecher, U. P., Kesäniemi, Y. A., & Fisher, M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.10.3204 · Cited by 91
Chesne, S., Rondeau, P., Armenta, S., & Bourdon, E. (2006) · Biochimie · doi:10.1016/j.biochi.2006.05.011 · Cited by 90
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
Wetzels, S., Wouters, K., Schalkwijk, C. G., Vanmierlo, T., & Hendriks, J. J. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020421 · Cited by 88
Investigations on oxidative stress and therapeutical implications in dementia
Durany, N., Münch, G. W., Michel, T. M., & Riederer, P. F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014177 · Cited by 86
Wrolstad, R. E. (2012) · Wiley eBooks · doi:10.1002/9781118688496 · Cited by 82
Glycation and Insulin Resistance: Novel Mechanisms and Unique Targets?
Song, F., & Schmidt, A. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241877 · Cited by 81
Nishimoto, S., Koike, S., Inoue, N., Suzuki, T., & Ogasawara, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.024 · Cited by 78
RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes
Daffu, G. K., Shen, X., Senatus, L. M., Thiagarajan, D., Abedini, A., del Pozo, C. H., Rosario, R., Song, F., Friedman, R. A., Ramasamy, R., et al. (2015) · Diabetes · doi:10.2337/db15-0575 · Cited by 77
Pathological Significance of Mitochondrial Glycation
Pun, P. B. L., & Murphy, M. P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/843505 · Cited by 76
Ravelojaona, V., Robert, A. M., & Robert, L. (2008) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.12.004 · Cited by 73
Advanced Glycation End Products in Renal Failure
Thornalley, P. J. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.012 · Cited by 73
A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti- IgG-AGE
Ligier, S. (1998) · British journal of rheumatology · doi:10.1093/rheumatology/37.12.1307 · Cited by 72
Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells
Ren, X., Shao, H., Wei, Q., Sun, Z., & Liu, N. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700329 · Cited by 72
Diabetes mellitus and the skin
Makrantonaki, E., Jiang, D., Hossini, A. M., Nikolakis, G. D., Wlaschek, M., Scharffetter‐Kochanek, K., & Zouboulis, C. C. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9373-0 · Cited by 72
Zhu, P., Yang, C. H., Chen, L., Ren, M., Lao, G., & Yan, L. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1102-z · Cited by 71
Choudhuri, S., Dutta, D., Sen, A., Chowdhury, I. H., Mitra, B., Mondal, L. K., Saha, A., Bhadhuri, G., & Bhattacharya, B. (2013) · PubMed Central · Cited by 70
Paun, A., & Danska, J. S. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12424 · Cited by 67
Pageon, H., Técher, M.-P., & Asselineau, D. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.04.004 · Cited by 66
The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis
Needell, J. C., & Zipris, D. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0781-z · Cited by 65
Tiwari, S. S., Mizuno, K., Ghosh, A., Aziz, W., Troakes, C., Daoud, J., Golash, V., Noble, W., Hortobágyi, T., & Giese, K. P. (2016) · Brain · doi:10.1093/brain/aww205 · Cited by 65
Saïd, G. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00033-3 · Cited by 63
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease
Münch, G. W., Cunningham, A. M., Riederer, P. F., & Braak, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00328-x · Cited by 63
Mir, A. R., Uddin, M., Alam, K., & Ali, A. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.05.057 · Cited by 62
Yoshinaga, E., Kawada, A., Ono, K., Fujimoto, E., Wachi, H., Harumiya, S., Nagai, R., & Tajima, S. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.298 · Cited by 61
RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress
Ihm (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000529 · Cited by 60
RAGE and its Ligands in Retinal Disease
Barile, G. R., & Schmidt, A. M. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220778 · Cited by 59
Ajith, T. A., & Vinodkumar, P. (2016) · Current Clinical Pharmacology · doi:10.2174/1574884711666160511150028 · Cited by 59
Chen, J., Jing, J., Yu, S., Song, M., Tan, H., Cui, B., & Huang, L. (2016) · PubMed Central · Cited by 59
Immune Complexes of LDL Induce Atherogenic Responses in Human Monocytic Cells
Kiener, P. A., Rankin, B. M., Davis, P. M., Yocum, S. A., Warr, G. A., & Grove, R. I. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.990 · Cited by 55
Glycation of human high density lipoprotein by methylglyoxal: Effect on HDL-paraoxonase activity
Bacchetti, T., Masciangelo, S., Armeni, T., Bicchiega, V., & Ferretti, G. (2013) · Metabolism · doi:10.1016/j.metabol.2013.10.013 · Cited by 53
Role of High Mobility Group Box 1 (HMGB1) in Wound Healing
Zhang, Q., O’Hearn, S. F., Kavalukas, S. L., & Barbul, A. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.06.069 · Cited by 53
Advanced glycation end products in senile diabetic and nondiabetic patients with cataract
Gul, A., Rahman, M. A., Salim, A., & Sımjee, S. U. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.04.001 · Cited by 52
Diabetic nephropathy. Mechanisms of mesangial matrix expansion.
Abrass, C. K. (1995) · PubMed Central · Cited by 51
Diabetes and Dementia in Long‐Term Care
Tariot, P. N., Ogden, M. A., Cox, C., & Williams, T. F. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb07234.x · Cited by 49
Moheimani, F., Morgan, P. E., van Reyk, D. M., & Davies, M. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.02.007 · Cited by 48
Vascular Factors in Diabetes and Alzheimer's Disease
Taguchi, A. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0975 · Cited by 47
Holderied, A., Romoli, S., Eberhard, J. N., Konrad, L., Devarapu, S. K., Marschner, J. A., Müller, S., & Anders, H. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.160 · Cited by 46
Du, H., Li, P., Wang, J., Qing, X., & Li, W. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9744-8 · Cited by 45
Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1495-y · Cited by 45
Wang, D., Li, T., Ye, G., Shen, Z., Hu, Y., Mou, T., Yu, J., Li, S., Liu, H., & Li, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122697 · Cited by 42
AGEs, autofluorescence and renal function
Gerrits, E. G., Smit, A. J., & Bilo, H. J. G. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn634 · Cited by 40
Piroddi, M., Depunzio, I., Calabrese, V., Mancuso, C., Aisa, M. C., Binaglia, L., Minelli, A., Butterfield, A., & Galli, F. (2007) · Amino Acids · doi:10.1007/s00726-006-0433-8 · Cited by 39
Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly
Pastino, A. K., Greco, T. M., Mathias, R. A., Cristea, I. M., & Schwarzbauer, J. E. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.07.003 · Cited by 39
Redondo, M., Beltrán-Brotóns, J. L., Reales, J., & Ballesteros, S. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.07.013 · Cited by 38
Impairment by glycation of immunoglobulin G Fc fragment function
DOLHOFER, R., & Gerbitz, K.-D. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519009091067 · Cited by 37
Structural Analysis and Aggregation Propensity of Reduced and Nonreduced Glycated Insulin Adducts
Alavi, P., Yousefi, R., Amirghofran, S., Karbalaei‐Heidari, H. R., & Moosavi‐Movahedi, A. A. (2013) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-013-0207-1 · Cited by 37
Yao, Y., Yang, L., Lv, J., Huang, X., Yi, J., Pei, C.-G., & Shao, Y. (2015) · Europe PMC (PubMed Central) · Cited by 36
RAGE receptor and its soluble isoforms in diabetes mellitus complications
Oliveira, M. I. A., de Souza, E. M., Pedrosa, F. D. O., Rea, R. R., Alves, A. C., Picheth, G., & Rego, F. G. D. M. (2013) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442013000200004 · Cited by 34
Annibal, A., Riemer, T., Jovanović, O., Westphal, D., Griesser, E., Pohl, E. E., Schiller, J., Hoffmann, R., & Fedorova, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.011 · Cited by 34
DuPengtao, H., Wang, L., & Li, X. Q. (2012) · Cited by 34
Lucey, M., Newkirk, M. M., Neville, C., LePage, K. T., & Fortin, P. R. (2000) · PubMed · Cited by 30
Okano, Y., Masaki, H., & Sakurai, H. (2001) · Journal of Dermatological Science · doi:10.1016/s0923-1811(01)00114-1 · Cited by 27
Barwick, A., Tessier, J., de Jonge, X. J., Ivers, J. R., & Chuter, V. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000235 · Cited by 27
Hepatic disposal of advanced glycation end products during maturation and aging
Svistounov, D., Oteiza, A., Zykova, S. N., Sørensen, K. K., McCourt, P., McLachlan, A. J., McCuskey, R. S., & Smedsrød, B. H. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.03.005 · Cited by 24
Choudhuri, S., Dutta, D., Chowdhury, I. H., Mitra, B., Sen, A., Mondal, L. K., Mukhopadhyay, S., & Bhattacharya, B. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.031 · Cited by 24
Vieillissement moléculaire des protéines: Quel rôle en physiopathologie ?
Jaisson, S., Desmons, A., Gorisse, L., & Gillery, P. (2017) · médecine/sciences · doi:10.1051/medsci/20173302013 · Cited by 23
Risk Factors for Coronary Artery Disease and Acute Coronary Syndrome in Patients ≤40 Years Old
Alkhawam, H., Sogomonian, R., El‐Hunjul, M., Kabach, M., Syed, U. M., Vyas, N., Ahmad, S., & Vittorio, T. J. (2016) · Future Cardiology · doi:10.2217/fca-2016-0011 · Cited by 21
Galliera, E., Marazzi, M. G., Gazzaruso, C., Gallotti, P., Coppola, A., Montalcini, T., Pujia, A., & Corsi Romanelli, M. M. (2017) · Immunity & Ageing · doi:10.1186/s12979-017-0097-0 · Cited by 18
Stress responses of human retinal pigment epithelial cells to glyoxal
Roehlecke, C., Valtink, M., Frenzel, A., Goetze, D., Knels, L., Morawietz, H., & Funk, R. H. W. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3463-2 · Cited by 15
Pentosidine determination in CSF: a potential biomarker of Alzheimer’s disease?
Monacelli, F., Borghi, R., Pacini, D., Serrati, C., Traverso, N., & Odetti, P. R. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0829 · Cited by 14
Josse, D., & Masson, P. (2001) · PubMed · Cited by 14
Vinokur, V., Weksler‐Zangen, S., Berenshtein, E., Eliashar, R., & Chevion, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159908 · Cited by 5
Cited by
Global view of human protein glycosylation pathways and functions
Schjoldager, K. T., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,309
Toxicity of carbon tetrachloride, free radicals and role of antioxidants
Unsal, V., Cicek, M., & Sabancilar, İ. (2021) · Reviews on Environmental Health · doi:10.1515/reveh-2020-0048 · Cited by 320
Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus
Khosla, S., Samakkarnthai, P., Monroe, D. G., & Farr, J. N. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00555-5 · Cited by 260
Plasma membrane integrity: implications for health and disease
Ammendolia, D. A., Bement, W. M., & Brumell, J. H. (2021) · BMC Biology · doi:10.1186/s12915-021-00972-y · Cited by 257
Gutierrez‐Mariscal, F. M., Cardelo, M. P., de la Cruz, S., Alcala‐Diaz, J. F., Roncero‐Ramos, I., Guler, I., Vals‐Delgado, C., López‐Moreno, A., Luque, R. M., Delgado‐Lista, J., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901290 · Cited by 60
Metadata
- Authors
- Fournet, M., Bonté, F., & Desmoulière, A.
- Venue
- Aging and disease
- Publisher
- Aging and Disease
- Published
- 2018
- Volume
- 9
- Issue
- 5
- Pages
- 880
- ISSN
- 2152-5250 (ISSN-L)
- OpenAlex
- W2891028736
- Cited by
- 291
- References
- 185
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.